Oppenheimer top analyst Rick Schafer remains on the sidelines despite a “positive” fourth-quarter print released NXP Semiconductors NV (NASDAQ:NXPI) reported yesterday. With his …
Yesterday evening, Catabasis Pharmaceuticals Inc (NASDAQ:CATB) announced that lead candidate edasalonexent missed the primary endpoint in its Phase II proof-of-concept trial in Duchenne …
Fitbit Inc (NYSE:FIT) shares toppled 16% yesterday after the leading fitness wearables maker preannounced results that massively disappointed investors. Though Oppenheimer analyst Andrew …
Yesterday after the close, the FDA granted final approval to Synergy Pharmaceuticals Inc’s (NASDAQ:SGYP) Trulance (plecanatide), for the treatment of chronic constipation. However, Synergy …
Oppenheimer analyst Andrew Uerkwitz sees GoPro Inc (NASDAQ:GPRO) in the center of a period of flux, and subsequently, the upheaval presents its own …
Amazon.com, Inc.
Oppenheimer analyst Leah R. Cann has reiterated her Buy rating for Celgene Corporation (NASDAQ: CELG) after the firm’s pipeline drug Otezla has now become …
Oppenheimer analyst Andrew Uerkwitz is weighing in on Fitbit Inc (NYSE:FIT) after finishing up a corporate wellness program. Even though FIT stock has …
In a research report released Tuesday, Oppenheimer analyst Jason Helfstein upgraded shares of Pandora Media Inc (NYSE:P) from Perform to Outperform, while establishing a …
FireEye Inc (NASDAQ:FEYE) held a Defense Summit Conference yesterday that has Oppenheimer top analyst Shaul Eyal out with bullish praise for the company, …
